NXS 4.76% 25.0¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 March 2024, page-13

  1. 85 Posts.
    lightbulb Created with Sketch. 25
    Mate the preso online today on zoom was excellent byIV.
    very strong realignment strategy, new sales force with variable cost model. Saving 6 m a year! Understand peoples frustration ; but Has taken a 1/4 to reset the structure; more then I thought. But understand.

    Yes a short term effect on sales upsets some people but ultimately will create better outcomes this year!
    Some key points in zoom iv preso worth portraying are:

    already hit 100 payors in April. 92 March
    April showing revenue returned growth values already
    6 m pa savings in new sales restructure
    more clinical data available 24
    still BEP 24 and hold guidance 36-40 m
    short term debt facility setup - only if necessary
    Zero debt the company

    I personally accumulate more in 30s. Very bullish - even more now; but I am a LT holder and always a 10 year hold and accumulate for me.

    cheers
    MTM



 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.013(4.76%)
Mkt cap ! $72.92M
Open High Low Value Volume
26.5¢ 27.0¢ 25.0¢ $18.39K 70.75K

Buyers (Bids)

No. Vol. Price($)
1 20530 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 45500 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
26.0¢
  Change
-0.013 ( 0.00 %)
Open High Low Volume
27.0¢ 27.0¢ 26.0¢ 21249
Last updated 15.08pm 14/06/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.